Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 9.749.386.306.235.12

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.74 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20259.74
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 9.74
3.84
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,218.7 Cr 6.5% -1.8% 8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 6.5% 23.3% 25.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,108.0 Cr 2.6% 3% 33.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.1% -0.2% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 2.6% -13.3% -10.7% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

6.5%

-1.8%

8.3%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses